Lunai Bioworks Inc. Gain (Loss) on Disposition of Assets
Lunai Bioworks Inc. (LNAI) reported Gain (Loss) on Disposition of Assets of -$18.17 thousand for the 12-month period ending 2022-06-30, per its 10-K filed 2023-10-02.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnDispositionOfAssets1 · last filed 2023-10-02
- Lunai Bioworks Inc. gain (loss) on disposition of assets for fiscal 2022 was -$18.17K.
| Period end | Gain (Loss) on Disposition of Assets 12 month |
|---|---|
| 2022-06-30 | -$18.17K 10-K · filed 2023-10-02 |
| 2013-12-31 | $1.00 10-Q · filed 2014-08-14 |
| 2012-12-31 | $15.02K 10-Q · filed 2014-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |